Vaccine scandal is latest in China's notorious history of substandard infant products | South China Morning Post

Chinese pharmaceutical company Changchun Changsheng Bio-technology has been found to have sold more than 250,000 substandard DPT vaccines to a public health agency in eastern China’s Shandong province. It's not the first time China has been gripped by a scandal over the quality of infant goods, and many parents rema…

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.